Food and Drug Regulations (C.R.C., c. 870)

G.03.017.3. The Minister must provide the licensed dealers, pharmacies and provincial professional licensing authorities who were issued a notice under subsection G.03.017.2(1) with a notice of retraction of that notice if

• (a) in the circumstance described in paragraph G.03.017.2(2)(a), the requirements set out in subparagraphs (b)(i) and (ii) have been met and one year has elapsed since the notice was issued by the Minister; or

• (b) in a circumstance described in any of paragraphs G.03.017.2(2)(b) and (c) and (4)(a) to (f), the pharmacist named in the notice has

  • (i) requested in writing that a retraction of the notice be issued, and

  • (ii) provided a letter from the provincial professional licensing authority of the province in which the pharmacist is registered or entitled to practise, in which the authority consents to the retraction of the notice.

G.03.017.4. and G.03.017.5. [Repealed, SOR/2003-135, s. 5]

• G.04.001. (1) In this section,

  “administer”

  “administer” includes to prescribe, sell or provide; (administrer)

  “designated drug”

  “designated drug” means any of the following controlled drugs:

  • (a) amphetamine and its salts,

  • (b) benzphetamine and its salts,

  • (c) methamphetamine and its salts,

  • (d) phenmetrazine and its salts, or

  • (e) phendimetrazine and its salts. (drogue désignée)

• (2) Subject to subsections (3) and (4) and to an exemption granted under section 56 of the Controlled Drugs and Substances Act with respect to the administration of the controlled drug specified in the exemption, no practitioner shall administer a controlled drug to any person or animal.

• (3) A practitioner may administer a controlled drug, other than a designated drug, to a person or to an animal, if

  • (a) that person or animal is a patient under his professional treatment; and

  • (b) the controlled drug is required for the condition for which the patient is receiving treatment.

• (4) A practitioner of medicine, dentistry or veterinary medicine or a nurse practitioner may administer a designated drug to an animal or a person who is a patient under their professional treatment if the designated drug is for the treatment of any of the following conditions:

  • (a) in humans

    • (i) narcolepsy,

    • (ii) hyperkinetic disorders in children,

    • (iii) [Repealed, SOR/2012-230, s. 12]

    • (iv) epilepsy,

    • (v) parkinsonism, or

    • (vi) hypotensive states associated with anesthesia; or

  • (b) in animals, depression of cardiac and respiratory centres.